Loading clinical trials...
Loading clinical trials...
To characterize the pharmacokinetics of G3139 in subjects with normal, mildly impaired, and moderately impaired renal function who receive Genasense 3 mg/kg/day by continuous intravenous infusion for ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genta Incorporated
NCT04656795 · Renal Impairment, Normal Renal Function
NCT02431481 · Normal Renal Function, Impaired Renal Function
NCT02338323 · Chronic Kidney Disease, Hyperuricemia, and more
NCT03226327 · Hypertension, Hypertension With Abnormal Renal Function
NCT02478086 · Abnormal Renal Function, Malnutrition
DaVita Clinical Research
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions